Thorax

Thorax is a peer-reviewed respiratory medicine journal published by BMJ on behalf of the British Thoracic Society, founded in 1946 and covering all areas of respiratory medicine and critical care, and it holds a 2025 Journal Impact Factor of 9.1《胸腔》（Thorax）是英国医学杂志出版集团（BMJ）代表英国胸科学会（British Thoracic Society）出版的同行评审呼吸医学期刊，1946 年创刊，涵盖呼吸医学与危重症医学的各个领域，2025 年影响因子为 9.1。

Scope

• Thorax publishes clinical and experimental research articles on respiratory medicine, critical care, paediatrics, immunology, pharmacology, pathology and surgery该刊发表呼吸医学、危重症医学、儿科学、免疫学、药理学、病理学与外科学方面的临床与实验研究论文。
• It seeks to publish significant advances in scientific understanding that are likely to impact on clinical practice该刊致力于发表可能影响临床实践的重大科学认识进展。
• It welcomes articles concerning basic and translational mechanisms with application to clinical material该刊欢迎与临床材料相关的基础与转化机制研究文章。
• Article types include original research, short reports, editorials and state of the art reviews其文章类型包括原创研究、短篇报告、社论与最新进展综述。
• They also include controversies and challenges in respiratory medicine, guidelines in context and pulmonary puzzles还包括呼吸医学中的争议与挑战、指南解读与肺科谜题。
• Further types are images in Thorax, journal club, BTS clinical statements and BTS guidelines其他类型还有胸腔影像、期刊俱乐部、英国胸科学会临床声明与英国胸科学会指南。
• It is a companion to the open access BMJ Open Respiratory Research该刊是开放获取期刊（BMJ Open Respiratory Research）的姊妹刊。

History

• Thorax was born in March 1946 as the official journal of the Thoracic Society, edited jointly by J G Scadding and N R Barrett该刊于 1946 年 3 月创刊，为胸科学会的会刊，由 J G Scadding 与 N R Barrett 联合主编。
• It began as a quarterly journal whose first issue contained nineteen articles, most of them on thoracic surgery, pathology and tuberculosis该刊起初为季刊，首期仅刊载十九篇文章，多数涉及胸外科、病理学与结核病。^[1]
• The Thoracic Society merged with the British Thoracic Association in 1982 to form the British Thoracic Society1982 年，胸科学会与英国胸科协会合并，组成英国胸科学会（BTS）。
• The journal moved to monthly publication around 1980 as the volume of work grew随着工作量增长，该刊约在 1980 年改为月刊。^[2]
• It is co-owned by the British Thoracic Society and BMJ, and is published by BMJ Publishing Group该刊由英国胸科学会与（BMJ）共同拥有，并由（BMJ）出版集团出版。
• It carries the print identifier 0040-6376 and the electronic identifier 1468-3296其印刷刊号为 0040-6376，电子刊号为 1468-3296。
• Its Journal Impact Factor moved from 9.139 in 2021 and 9.102 in 2022 to 7.7 in 2024 and 9.1 in 2025其影响因子由 2021 年的 9.139 与 2022 年的 9.102 变为 2024 年的 7.7 与 2025 年的 9.1。
• It follows a subscription model with a hybrid open access option, and celebrated its 80th anniversary in 2026该刊采用订阅制并设有混合开放获取选项，并于 2026 年迎来创刊八十周年。^[3]

Editors

• Thorax is led by three joint Editors-in-Chief, Mark Griffiths and Jennifer Quint of Imperial College London and Cecilia O'Kane of Queen's University Belfast该刊由三位联合主编领导，即（Imperial College London）的 Mark Griffiths 与 Jennifer Quint，以及（Queen's University Belfast）的 Cecilia O'Kane。
• Deputy Editors are Alex Bottle of Imperial College London and Rachel Chambers of University College London副编辑为（Imperial College London）的 Alex Bottle 与（University College London）的 Rachel Chambers。
• Associate Editors include Mona Bafadhel of King's College London, Kevin Blyth of the University of Glasgow and Matthew Callister of Leeds Teaching Hospitals副编辑还包括（King's College London）的 Mona Bafadhel、（University of Glasgow）的 Kevin Blyth 与（Leeds Teaching Hospitals）的 Matthew Callister。
• The broader board spans the United Kingdom, the United States, India, Australia, Uganda, South Africa and China, among other countries更广的编委会横跨英国、美国、印度、澳大利亚、乌干达、南非与中国等多个国家。
• Articles submitted to Thorax undergo single anonymised peer review, in which reviewers' names are hidden from the authors投稿该刊的文章须经单盲同行评审，评审人姓名对作者匿名。
• Potentially acceptable papers receive statistical analysis, and manuscripts are discussed at the weekly editorial committee before a decision可能被接收的论文须经统计分析，并在每周编辑委员会上讨论后才作出决定。
• Thorax accepts about 16 percent of submissions, with a median of 57 days to first decision after review该刊的接收率约为 16%，评审后首次决定的中位时间为 57 天。